Ziopharm Oncology (ZIOP) Misses Q2 EPS Views
Tweet
Share
E-mail
Get Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
Total operating expenses: 12.51M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Financial Fact:
Total operating expenses: 12.51M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q2 EPS of ($1.01), $0.90 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.52 million.
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Capitol Federal Financial (CFFN) Misses Q2 EPS by 1c
- Stock Yards Bancorp (SYBT) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
